News and Announcements
DomaCom Appointments a New Chief Financial Officer
- Published May 09, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
DomaCom Limited (ASX: DCL) is pleased to advise that Philip Chard ACA has been appointed as Chief Financial Officer.
KEY TAKEAWAYS:
- Philip has over 25 years of experience in the financial services industry. As a senior manager at Deloitte he provided assurance and advisory services within the funds management and investment banking sectors.
- Philip has held a broad range of financial control and reporting positions within the property, funds management and banking sectors.
Philip joined DomaCom in 2015 as Financial Controller and has established strong financial reporting and financial management processes. In February 2016, he was also appointed as Company Secretary to DomaCom Limited. Ross Laidlaw who is an Executive Director of DomaCom and has held the dual roles of COO and CFO, will relinquish the role of CFO.
DomaCom CEO, Arthur Naoumidis, said, “We are excited to announce Philip’s appointment as Chief Financial Officer. His extensive experience in building and enhancing financial systems and processes will be invaluable as DomaCom continues to expand its customer base and product offerings.”
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
